91Ó°ÊÓ

Refer to a study on the effectiveness of an HPV (human papilloma virus) vaccine conducted between October 1998 and November \(1999 .\) HPV is the most common sexually transmitted infection-more than 20 million Americans are infected with HPV-but most HPV infections are benign, and in most cases infected individuals are not even aware they are infected. (On the other hand, some HPV infections can lead to cervical cancer in women.) The researchers recruited 2392 women from 16 different centers across the United States to participate in the study through advertisements on college campuses and in the surrounding communities. To be eligible to participate in the study, the subjects had to meet the following criteria: (1) be a female between 16 and 23 years of age, (2) not be pregnant, (3) have no prior abnormal Pap smears, and (4) report to have had sexual relations with no more than five men. At each center, half of the participants were randomly selected to receive the HPV vaccine, and the other half received a placebo injection. After 17.4 months, the incidence of HPV infection was 3.8 per 100 woman-years at risk in the placebo group and 0 per 100 woman-years at risk in the vaccine group. In addition, all nine cases of HPV-related cervical precancerous growths occurred among the placebo recipients. (a) Describe the treatment group in the study. (b) Could this study be considered a double-blind, randomized controlled placebo study? Explain.

Step by step solution

01

Definition of the Treatment Group

The treatment group refers to the subjects in an experiment who receive the treatment or the intervention whose effect the researchers want to analyze. In this case, the treatment group consisted of the participants who received the HPV vaccine.

02

Explanation of a Double-Blind Randomized Controlled Placebo Study

A double-blind randomized controlled placebo study is a type of experimental design in which neither the participants nor the researchers know who receives the real treatment and who receives the placebo. This design is used to avoid bias in the results.

03

Determining if the study is a Double-Blind Randomized Controlled Placebo Study

Based on the data provided in the exercise, the study can be deemed as a randomized controlled placebo study as it included a treatment (HPV vaccine) and control (placebo) group, and the participants were randomly assigned to these groups. However, the exercise does not provide explicit information to confirm if it was a double-blind study.

Unlock Step-by-Step Solutions & Ace Your Exams!

• Full Textbook Solutions

  Get detailed explanations and key concepts

• Unlimited Al creation

  Al flashcards, explanations, exams and more...

• Ads-free access

  To over 500 millions flashcards

• Money-back guarantee

  We refund you if you fail your exam.

Over 30 million students worldwide already upgrade their learning with 91Ó°ÊÓ!

Key Concepts

These are the key concepts you need to understand to accurately answer the question.

HPV Vaccine Studies

Human papilloma virus (HPV) is the most common sexually transmitted infection. It affects millions annually, yet many remain unaware of being infected, often showing no symptoms. However, certain strains can lead to serious health issues like cervical cancer in women. Studies on HPV vaccines aim to prevent these dangerous strains and reduce infections.

Typically, these studies involve selecting participants who meet specific criteria to ensure accurate results. For instance, in the exercise referenced, women between the ages of 16 and 23, who had no prior abnormal Pap smears and limited sexual partners, were chosen. This specific demographic is crucial for understanding the vaccine's efficacy in the chosen at-risk population.

During HPV vaccine studies, two groups are typically involved: a treatment group receiving the vaccine and a control group receiving a placebo. By observing these groups over a certain period, researchers can determine the vaccine's effectiveness at preventing HPV infections and related conditions, such as cervical precancerous growths.

Double-Blind Method

The double-blind method is a gold standard in experimental designs, especially in clinical trials. In this method, neither participants nor researchers know who receives the actual treatment or the placebo. This approach is essential to remove bias, which can subtly influence outcomes. For instance, researchers might unknowingly give more attention to patients receiving the actual treatment if they were aware of the group allocations.

By keeping both parties "blind," the double-blind method ensures that observed effects are due solely to the treatment itself and not external influences. This method is crucial in ensuring the reliability and validity of a study's results. In the context of the HPV vaccine study, although the exercise didn't confirm a double-blind approach, implementing it would further bolster the trustworthiness of the conclusions drawn from the data.

Placebo Effect

The placebo effect is a fascinating phenomenon wherein patients experience real changes in their condition despite receiving a non-active treatment. When participants believe they are receiving actual treatment, their expectations can lead to perceived or real improvements.

In clinical trials, like the HPV vaccine study referenced, using a placebo group helps distinguish effects due to the actual vaccine from those due to the psychological impact of receiving a treatment.

For example, if participants who received the placebo injection show any changes in their condition, these could be attributed to the placebo effect. However, since the placebo group in the study didn't show improvements in preventing HPV-related conditions, it underscores the actual effectiveness of the HPV vaccine in the treatment group. Conducting studies with placebo groups is crucial for accurately identifying and validating the effects of new treatments.